Gina N Grantham

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 20

Top Topics

Endometrial Cancer

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Radical Prostatectomy

Top Venues

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Timothy L Cannon, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Vi K Chiu, Jimmy Hwang, Namrata Vijayvergia, Olatunji B Alese, Elie G Dib, Herbert L Duvivier, Kelsey A Klute, Vaibhav Sahai, Eugene R Ahn, Pablo Bedano, Deepti Behl, Sarah Sinclair, Ramya Thota, Walter J Urba, Eddy Shih-Hsin Yang, Gina N Grantham, Dominique C Hinshaw, Abigail Gregory, Susan Halabi, Richard L Schilsky
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Gordan Srkalovic, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn, Gregory Brouse, John Chan, Inderjit Mehmi, Maya Khalil, Herbert L Duvivier, Anu Gaba, Harshraj Leuva, Ramya Thota, Kathleen J Yost, Gina N Grantham, Abigail Gregory, Dominique C Hinshaw, Susan Halabi, Richard L Schilsky
Talazoparib in Patients With Solid Tumors With BRCA1 / 2 Mutation: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO precision oncology 8 (2024)
Carmen J Calfa, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn, Monika L Burness, Keerthi Gogineni, Nitin Rohatgi, Tareq Al Baghdadi, Alison Conlin, Anu Gaba, Omid Hamid, Jairam Krishnamurthy, Naga Jyothi Gavini, Philip J Gold, Jordi Rodon Ahnert, J Scott Roberts, Ramya Thota, Gina N Grantham, Dominique C Hinshaw, Abigail Gregory, Susan Halabi, Richard L Schilsky
Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO precision oncology 8 (2024)
Vaibhav Sahai, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Vijay Suhag, Elie G Dib, Inderjit Mehmi, Kunal C Kadakia, Evan Pisick, Herbert L Duvivier, Phat H Le, Rui Li, David P Michelin, Ryan E Wilcox, Gina N Grantham, Dominique C Hinshaw, Abigail Gregory, Susan Halabi, Richard L Schilsky
Regorafenib in Patients With Solid Tumors With BRAF Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. JCO precision oncology 8 (2024)
Gordan Srkalovic, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn, Gregory Brouse, John Chan, Inderjit Mehmi, Maya Khalil, Herbert L Duvivier, Anu Gaba, Harshraj Leuva, Ramya Thota, Kathleen J Yost, Gina N Grantham, Abigail Gregory, Dominique C Hinshaw, Susan Halabi, Richard L Schilsky
Talazoparib in Patients With Solid Tumors With BRCA1 / 2 Mutation: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO precision oncology 8 (2024)
Scott M Schuetze, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Funda Meric-Bernstam, Carmen J Calfa, Laura Catherine Farrington, Michael B Livingston, Kristopher Wentzel, Deepti Behl, Yelena Kier, Alissa S Marr, Margaret von Mehren, Joshua Z Press, Ramya Thota, Gina N Grantham, Abigail Gregory, Dominique C Hinshaw, Susan Halabi, Richard L Schilsky
Palbociclib in Patients With Soft Tissue Sarcoma With CDK4 Amplifications: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO precision oncology 8 (2024)
Scott M Schuetze, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Funda Meric-Bernstam, Carmen J Calfa, Laura Catherine Farrington, Michael B Livingston, Kristopher Wentzel, Deepti Behl, Yelena Kier, Alissa S Marr, Margaret von Mehren, Joshua Z Press, Ramya Thota, Gina N Grantham, Abigail Gregory, Dominique C Hinshaw, Susan Halabi, Richard L Schilsky
Palbociclib in Patients With Soft Tissue Sarcoma With CDK4 Amplifications: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO precision oncology 8 (2024)
Funda Meric-Bernstam, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Rodolfo Gutierrez, Eugene R Ahn, Timothy L Cannon, Steven Francis Powell, John C Krauss, Christopher M Reynolds, Margaret von Mehren, Deepti Behl, Carmen J Calfa, Herbert L Duvivier, Henry G Kaplan, Michael B Livingston, Manish R Sharma, Walter J Urba, Gina N Grantham, Dominique C Hinshaw, Abigail Gregory, Susan Halabi, Richard L Schilsky
Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO precision oncology 7 (2023)
Funda Meric-Bernstam, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Rodolfo Gutierrez, Eugene R Ahn, Timothy L Cannon, Steven Francis Powell, John C Krauss, Christopher M Reynolds, Margaret von Mehren, Deepti Behl, Carmen J Calfa, Herbert L Duvivier, Henry G Kaplan, Michael B Livingston, Manish R Sharma, Walter J Urba, Gina N Grantham, Dominique C Hinshaw, Abigail Gregory, Susan Halabi, Richard L Schilsky
Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO precision oncology 7 (2023)
Eddy Shih-Hsin Yang, Susan Halabi, Michael Rothe, Elizabeth Garrett-Mayer, Pam K Mangat, Evan Pisick, Elie G Dib, Earle F Burgess, Michael Zakem, Nitin Rohatgi, Mehmet A Bilen, Raegan O'Lone, Gina N Grantham, Richard L Schilsky
Olaparib in Patients With Metastatic Prostate Cancer With BRCA1 / 2 Mutation: Results From the TAPUR Study. JCO precision oncology 7 (2023)
Eugene R Ahn, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Hussein M Ali-Ahmad, John K Chan, Michael L Maitland, Sapna R Patel, Zachary Reese, Ani S Balmanoukian, Charles W Drescher, Rui Li, Apostolia-Maria Tsimberidou, Charles A Leath, Raegan O'Lone, Gina N Grantham, Susan Halabi, Richard L Schilsky
Pertuzumab Plus Trastuzumab in Patients With Endometrial Cancer With ERBB2/3 Amplification, Overexpression, or Mutation: Results From the TAPUR Study. JCO precision oncology 7 (2023)
Eddy Shih-Hsin Yang, Susan Halabi, Michael Rothe, Elizabeth Garrett-Mayer, Pam K Mangat, Evan Pisick, Elie G Dib, Earle F Burgess, Michael Zakem, Nitin Rohatgi, Mehmet A Bilen, Raegan O'Lone, Gina N Grantham, Richard L Schilsky
Olaparib in Patients With Metastatic Prostate Cancer With BRCA1 / 2 Mutation: Results From the TAPUR Study. JCO precision oncology 7 (2023)
Funda Meric-Bernstam, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Rodolfo Gutierrez, Eugene R Ahn, Timothy L Cannon, Steven Francis Powell, John C Krauss, Christopher M Reynolds, Margaret von Mehren, Deepti Behl, Carmen J Calfa, Herbert L Duvivier, Henry G Kaplan, Michael B Livingston, Manish R Sharma, Walter J Urba, Gina N Grantham, Dominique C Hinshaw, Abigail Gregory, Susan Halabi, Richard L Schilsky
Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO precision oncology 7 (2023)
Herbert L Duvivier, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn, Tareq Al Baghdadi, Ajjai S Alva, Stephanie A Dublis, Timothy L Cannon, Carmen J Calfa, Rui Li, Deepti Behl, Vi K Chiu, Philip J Gold, Alissa S Marr, Kathryn F Mileham, Steven Francis Powell, Jordi Rodon Ahnert, Ramya Thota, Gina N Grantham, Abigail Gregory, Dominique C Hinshaw, Susan Halabi, Richard L Schilsky
Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Funda Meric-Bernstam, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Rodolfo Gutierrez, Eugene R Ahn, Timothy L Cannon, Steven Francis Powell, John C Krauss, Christopher M Reynolds, Margaret von Mehren, Deepti Behl, Carmen J Calfa, Herbert L Duvivier, Henry G Kaplan, Michael B Livingston, Manish R Sharma, Walter J Urba, Gina N Grantham, Dominique C Hinshaw, Abigail Gregory, Susan Halabi, Richard L Schilsky
Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO precision oncology 7 (2023)
Eddy Shih-Hsin Yang, Susan Halabi, Michael Rothe, Elizabeth Garrett-Mayer, Pam K Mangat, Evan Pisick, Elie G Dib, Earle F Burgess, Michael Zakem, Nitin Rohatgi, Mehmet A Bilen, Raegan O'Lone, Gina N Grantham, Richard L Schilsky
Olaparib in Patients With Metastatic Prostate Cancer With BRCA1 / 2 Mutation: Results From the TAPUR Study. JCO precision oncology 7 (2023)
Apar Kishor Ganti, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Elie G Dib, Herbert L Duvivier, Eugene R Ahn, Deepti Behl, Hossein Borghaei, Ani S Balmanoukian, Anu Gaba, Rui Li, Kwabena Osei-Boateng, Ramya Thota, Gina N Grantham, Abigail Gregory, Susan Halabi, Richard L Schilsky
Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With ERBB2 Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO precision oncology 7 (2023)
Nitin Rohatgi, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Funda Meric-Bernstam, Evan Pisick, Olatunji B Alese, Christopher M Reynolds, Ramya Thota, Gina M Vaccaro, Margaret von Mehren, Rebecca C Arend, Vi K Chiu, Herbert L Duvivier, Philip J Gold, Keely Hack, Alissa S Marr, Arthur Winer, Gina N Grantham, Dominique C Hinshaw, Abigail Gregory, Susan Halabi, Richard L Schilsky
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With ATM Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. JCO precision oncology 7 (2023)
Ranju Gupta, Funda Meric-Bernstam, Michael Rothe, Elizabeth Garrett-Mayer, Pam K Mangat, Stacy D'Andre, Eugene R Ahn, Raegan O'Lone, Susan Halabi, Gina N Grantham, Richard L Schilsky
Pertuzumab Plus Trastuzumab in Patients With Colorectal Cancer With <i>ERBB2</i> Amplification or <i>ERBB2/3</i> Mutations: Results From the TAPUR Study. JCO precision oncology 6 (2022)
Kelsey A Klute, Michael Rothe, Elizabeth Garrett-Mayer, Pam K Mangat, Reza Nazemzadeh, Kathleen J Yost, Herbert L Duvivier, Eugene R Ahn, Timothy L Cannon, Olatunji B Alese, John C Krauss, Ramya Thota, Carmen J Calfa, Crystal S Denlinger, Raegan O'Lone, Susan Halabi, Gina N Grantham, Richard L Schilsky
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. JCO precision oncology 6 (2022)